In order to better understand the relationship between ALKBH5/TIRAP axis and RILI and HCC radiosensitivity, we collected samples from patients responding to radiotherapy without concomitant RILI and patients showing nonresponse to radiotherapy but with concomitant RILI. Here, ALKBH5 is linked to hepatocellular carcinoma.